Audacious Brands Has A First Mover Advantage In One Of Asias Key Growth Markets

2022 is less than a month away and we are highly focused on identifying cannabis companies that have been executing on core growth initiatives and that are trading at a discount when compared to competitors.

So far this year, one of the most significant themes of the cannabis industry has been related to international markets that are starting to make meaningful contributions to the size of the global cannabis industry. Some of the international markets that we have a long-term bullish outlook on are Colombia, Germany, Israel, and Mexico.

Southeast Asia is another region that we are excited about and closely following how the industry advances in 2022. When it comes to medical cannabis markets in Southeast Asia, we are highly focused on Australia. When it comes to hemp and CBD from hemp markets in the region, we are excited about the legislation that was passed in Thailand.

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) is a cannabis company that has been focused on the global opportunity and we believe the business is well positioned to record strong growth in 2022 and beyond. Through a majority owned subsidiary, ALPS, the company has entered into contracts with cannabis and non-cannabis businesses.

We are bullish on the geographic diversity that ALPS brings to Australis and consider this to be a core pillar of the story. Through ALPS, the company has secured contracts or are in late-stage negotiations in the following jurisdictions: Australia, United Arab Emirates (UAE), Bahrain, Canada, Finland, Germany, Iceland, Jordan, Kuwait, Netherlands, Saudi Arabia, and Denmark.

During the most recent quarter, ALPS completed a comprehensive paid-for feasibility study for a large investment fund in the UAE and signed a contract for an expansion in the Middle East to develop a 1 million+ sq. ft. facility to cultivate fresh fruits and vegetables in Kuwait. We consider these developments to be important growth drivers for Australis and will monitor how the international side of the business continues to evolve.

Last month, Australis reported an important milestone with its international expansion strategy and formed a strategic partnership with Golden Triangle Health (GTH), a subsidiary of NR Instant Produce PCL (NRF), a leading southeast Asian food manufacturer and distributor based in Thailand, producing its own signature brands private label products and co-packaging lines.

The goal of the partnership is to develop GTH into a leading cannabidiol (CBD) operator in the Asian market. Through the partnership, Australis has the potential to become an export partner for GTH’s product portfolio in Thailand. The company will own up to 25% of GTH and we will monitor how the partnership supports growth in the year to come.

Although Australis has been nothing short of an execution story in the US and abroad, the recent trend has been to the downside. At current levels, we find the risk-reward profile to be favorable and believe that the business has significant growth catalysts. When compared to its peers, Australis is trading at a considerable discount (based on the market capitalization) and this is an opportunity that our readers should be aware of.

Pursuant to an agreement between StoneBridge Partners LLC and Australis Capital Inc. we have been hired for a period of 180 days beginning September 13, 2021 and ending on March 13, 2022 to publicly disseminate information about (AUSA) including on the Website and other media including Facebook and Twitter. We are being paid $5,000 per month (AUSA) for or were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of (AUSA) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (AUSA) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Top Stories